Profile
Paul F.
Reid was the founder of ReceptoPharm, Inc. founded in 2001, where he held the title of Chief Executive Officer from 2009 to 2011.
He was also the Chief Executive Officer of Nutra Pharma Corp.
from 2008 to 2010 and held the title of Head-Scientific Affairs at Biotherapeutics, Inc. in 1993.
Dr. Reid obtained a doctorate degree from Imperial College London and an undergraduate degree from Trinity College Dublin in 1987.
Former positions of Paul F. Reid
| Companies | Position | End |
|---|---|---|
| NUTRA PHARMA CORP. | President | 2009-11-17 |
Biotherapeutics, Inc.
 Biotherapeutics, Inc. BiotechnologyHealth Technology Biotherapeutics, Inc. operates as a pre-clinical stage company which develops small-molecule drugs to treat inflammation and type 2 diabetes. Its scientific foundation is anchored on informatics and computer modeling-enabled drug development with significant animal pharmacology validation. The company was founded by Josep Bassaganya-Riera in 2008 and is headquartered in Blacksburg, VA. | Corporate Officer/Principal | 1992-12-31 |
ReceptoPharm, Inc.
 ReceptoPharm, Inc. Pharmaceuticals: MajorHealth Technology ReceptoPharm, Inc. develops proprietary therapeutic protein products for the prevention and treatment of viral and neurological diseases. It provides benefits for patients with such diseases as acquired immunodeficiency syndrome, multiple sclerosis, myasthenia gravis, and other viral disorders. The company was founded on June 4, 2001 and is headquartered in Plantation, FL. | Chief Executive Officer | - |
Training of Paul F. Reid
| Imperial College London | Doctorate Degree |
| Trinity College Dublin | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NUTRA PHARMA CORP. | Retail Trade |
| Private companies | 2 |
|---|---|
ReceptoPharm, Inc.
ReceptoPharm, Inc. Pharmaceuticals: MajorHealth Technology ReceptoPharm, Inc. develops proprietary therapeutic protein products for the prevention and treatment of viral and neurological diseases. It provides benefits for patients with such diseases as acquired immunodeficiency syndrome, multiple sclerosis, myasthenia gravis, and other viral disorders. The company was founded on June 4, 2001 and is headquartered in Plantation, FL. | Health Technology |
Biotherapeutics, Inc.
Biotherapeutics, Inc. BiotechnologyHealth Technology Biotherapeutics, Inc. operates as a pre-clinical stage company which develops small-molecule drugs to treat inflammation and type 2 diabetes. Its scientific foundation is anchored on informatics and computer modeling-enabled drug development with significant animal pharmacology validation. The company was founded by Josep Bassaganya-Riera in 2008 and is headquartered in Blacksburg, VA. | Health Technology |
- Stock Market
- Insiders
- Paul F. Reid
